Connect with us

Legal & Regulation

Cannabis Legalization on Purview of Three Federal Agencies (DEA, FDA, EPA)



Cannabis Legalization on Purview of Three Federal Agencies (DEA, FDA, EPA)

The Food and Drug Administration (FDA), the Environmental Protection Agency (EPA), and the Drug Enforcement Administration (DEA) have the classification of cannabis under consideration. Cannabis is illegal under federal law and is classified as a Schedule I substance. Here is what each agency is specifically seeking comment on:

The FDA has reopened its comment period on a number of issues, including cannabis's status under international treaties. The agency’s notice states that it is “taking this action to allow interested persons additional time to submit comments.”

The EPA issued a news release. The EPA is seeking public comment on a narrow scope of information related to cannabis, which is the “pesticide applications for hemp.”

The notice reads that EPA Administrator Agency Wheeler stated,

“EPA is taking the next step toward registering crop protection tools for hemp in time for use during the 2020 application and growing seasons. The Agency is announcing a 30-day public comment period on ten existing pesticide product applications for industrial hemp. We hope this transparent and public process will bring hemp farmers and researchers increased regulatory clarity in time for next growing season — something they have asked for since the passage of the 2018 Farm Bill and the legalization of commercial hemp.”

As for the DEA, in its announcement of necessary steps to improve access to marijuana research, Attorney General William P. Barr stated,

“I am pleased that DEA is moving forward with its review of applications for those who seek to grow marijuana legally to support research. The Department of Justice will continue to work with our colleagues at the Department of Health and Human Services and across the Administration to improve research opportunities wherever we can.”

Further, the announcement reads concerning public comment,

“To ensure transparency and public participation, this process will provide applicants and the general public with an opportunity to comment on the regulations that should govern the program of growing marijuana for scientific and medical research.”

It appears that reportedly, the public has already started commenting. In an article by Marijuana Moment, several comments appear.

All information is for general informational and educational purposes only. Nothing should be interpreted as legal or wellness advice.

Jane is a regular contributor who learned about the great benefits of CBD a few years ago after starting it herself. Impressed by its effects, she's interested in helping others learn about options that can be helpful for them.

Continue Reading

Ultimate CBD Guide


ultimate-cbd-products-company-guidepopular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

TimesofCBD is the most active daily CBD news publication featuring the latest cannabis industry stories and marijuana market trends. As the leader in CBD-centric content curation, we invite all readers to come for the headlines and stay for the insights. Quality is the top priority when presenting user guides, analyzing product reviews and reporting fact-checked news announcements. All information is for educational and informational purposes only. Disclaimer.

Got news? Email

Copyright © 2020 | Latest CBD News, Cannabis Guides and Marijuana Trends
Note: Always seek real additional medical advice and consultation with a professional healthcare practitioner before considering any CBD. No statements found on this website have underwent Food and Drug Administration evaluation. The efficacy of any products or claims made have never been approved by the FDA either. No products shall ever be intended to diagnose, treat or cure any disease or prevent any ailment.